NasdaqGM - Delayed Quote USD

GCM Grosvenor Inc. (GCMG)

9.42 -0.02 (-0.21%)
At close: April 22 at 4:00 PM EDT

Earnings Estimate

CURRENCY IN USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
No. of Analysts 6666
Avg. Estimate 0.140.150.70.82
Low Estimate 0.130.140.670.77
High Estimate 0.160.170.760.93
Year Ago EPS 0.460.120.550.7

Revenue Estimate

CURRENCY IN USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
No. of Analysts 3333
Avg. Estimate 113.37M119.33M511M566.3M
Low Estimate 105.5M112M485.1M544.8M
High Estimate 123.6M128M534.9M577.1M
Year Ago Sales 96.4M104.1M445M511M
Sales Growth (year/est) 17.60%14.60%14.80%10.80%

Earnings History

CURRENCY IN USD 3/31/2023 6/30/2023 9/30/2023 12/31/2023
EPS Est. 0.110.110.140.17
EPS Actual 0.460.120.150.17
Difference 0.350.010.010
Surprise % 318.20%9.10%7.10%0.00%

EPS Trend

CURRENCY IN USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
Current Estimate 0.140.150.70.82
7 Days Ago 0.140.150.70.82
30 Days Ago 0.140.150.70.81
60 Days Ago 0.140.150.70.81
90 Days Ago 0.150.160.70.81

EPS Revisions

CURRENCY IN USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
Up Last 7 Days ----11
Up Last 30 Days ----12
Down Last 7 Days --------
Down Last 30 Days --------

Growth Estimates

CURRENCY IN USD GCMGIndustrySectorS&P 500
Current Qtr. -69.60%----0.20%
Next Qtr. 25.00%----9.40%
Current Year 27.30%----4.40%
Next Year 17.10%----13.40%
Next 5 Years (per annum) 10.99%----11.07%
Past 5 Years (per annum) 5.78%------

Research Analysis

Analyst Price Targets

9.00
10.70 Average
9.42 Current
14.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

Upgrades & Downgrades

Maintains UBS: Neutral to Neutral 4/12/2024
Upgrade TD Cowen: Market Perform to Outperform 2/16/2024
Maintains Oppenheimer: Outperform to Outperform 2/14/2024
Initiated TD Cowen: Market Perform 1/4/2024
Maintains Oppenheimer: Outperform to Outperform 10/9/2023
Maintains Piper Sandler: Overweight to Overweight 8/10/2023

Related Tickers